Education
  • Featured content
    In this module, Nancy Reau, MD, discusses recent clinical data on the management of HCV infection in harder-to-treat patient populations, including patients with cirrhosis, genotype 3 HCV infection, and HIV coinfection. Please join us for the corresponding dinner meeting series, where Dr. Reau and other faculty will apply the data shown here to the management of these key patient populations.
  • Featured content
    In this expert analysis, Jordan J. Feld, MD, MPH; Paul Y. Kwo, MD; and Stefan Zeuzem, MD, discuss the most clinically relevant data on the management of hepatitis C infection in patients with advanced liver disease, cirrhosis, liver transplantation, and HIV coinfection, as well as new advances in the treatment of hepatitis D infection.
  • Featured content
    In this Expert Analysis, Michael W. Fried, MD; David R. Nelson, MD; and Nancy Reau, MD, provide an in-depth review of the most clinically relevant new data presented at the 2014 American Association for the Study of Liver Disease conference on the management of HCV and other key topics, along with downloadable slides.
  • Featured content
    Nezam H. Afdhal, MD, FRCPI, reviews the impact of all-oral therapy on the management of HCV infection.
  • Featured content
    Nezam H. Afdhal, MD, FRCPI; Ira M. Jacobson, MD; Paul Y. Kwo, MD; and Norah Terrault, MD, MPH, discuss AASLD/IDSA guidance on the management of HCV infection using specific patient scenarios.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Educational Activities

10 of 217 Shown
10 of 217 Shown
Show 10 More
Loading...